Oncogenic Ras downregulates mdr1b expression through generation of reactive oxygen species

Semo Jun1, Seok Won Kim2, Byeol Kim1

  • 1Departments of Premedical Sciences, College of Medicine, Chosun University, Gwangju 61452, Korea.

Insights

Oncogenic H-Ras (V12) downregulates mdr1b expression and increases doxorubicin sensitivity in NIH3T3 cells. This effect involves reactive oxygen species (ROS) and ERK activation, suggesting potential therapeutic targets.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The multidrug resistance gene 1b (mdr1b) plays a crucial role in drug efflux and multidrug resistance.
  • Oncogenic mutations in signaling pathways, such as H-Ras, can alter cellular responses to chemotherapy.
  • Understanding the interplay between oncogenic signaling and drug resistance mechanisms is vital for cancer treatment.

Purpose of the Study:

  • To investigate the impact of oncogenic H-Ras (V12) on rat mdr1b expression in NIH3T3 cells.
  • To elucidate the underlying molecular mechanisms, including the role of reactive oxygen species (ROS) and the ERK pathway.
  • To explore the correlation between H-Ras expression, mdr1b regulation, and sensitivity to doxorubicin toxicity.

Main Methods:

  • Utilized NIH3T3 cells stably expressing oncogenic H-Ras (V12).
  • Assessed mdr1b promoter activity and mRNA expression.
  • Employed antioxidants (N-acetylcysteine) and NADPH oxidase inhibitors (diphenylene iodonium) to investigate ROS involvement.
  • Used ERK inhibitors (PD98059, U0126) to examine the role of the ERK pathway.
  • Evaluated doxorubicin-induced cell death and apoptosis.

Main Results:

  • Constitutive H-Ras (V12) expression significantly downregulated mdr1b promoter activity and mRNA levels.
  • H-Ras (V12) expression correlated positively with sensitivity to doxorubicin toxicity.
  • Antioxidant and NADPH oxidase inhibition treatments enhanced H-Ras-mediated mdr1b downregulation and protected against doxorubicin-induced cell death.
  • ERK pathway inhibition increased mdr1b promoter activity and reduced doxorubicin-induced apoptosis.

Conclusions:

  • Oncogenic H-Ras (V12) downregulates mdr1b expression, at least partly, through ROS production and subsequent ERK activation.
  • This mechanism contributes to increased sensitivity to doxorubicin toxicity.
  • Targeting ROS production or ERK signaling may represent a strategy to overcome H-Ras-mediated drug resistance.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.7K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.0K